Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine whether additional pharmaceutical care for elderly patients (home-cared patients, nursing-home residents) has a positive impact on drug-related readmissions.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
RWTH Aachen University
Collaborators
NCT07366424 · Falls in the Elderly
NCT07536568 · Sublingual, Caffeine, and more
NCT06811324 · Obesity Prevention, Sarcopenia in Elderly, and more
NCT06925880 · Sarcopenia in Elderly, Frailty at Older Adults, and more
NCT06645847 · Frail Elderly, Aging, and more
University Hospital Aachen
Aachen
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions